Muutke küpsiste eelistusi

Elsevier's 2027 Intravenous Medications 43rd edition [Spiraalköide]

(President, Drug Information Consultants, Chesapeake, Virginia, USA)
  • Formaat: Spiral bound, 1344 pages, kõrgus x laius: 229x152 mm, kaal: 450 g
  • Ilmumisaeg: 18-Jun-2026
  • Kirjastus: Churchill Livingstone
  • ISBN-10: 0443433364
  • ISBN-13: 9780443433368
Teised raamatud teemal:
  • Spiraalköide
  • Hind: 48,81 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 65,09 €
  • Säästad 25%
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 3-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
Elsevier's 2027 Intravenous Medications 43rd edition
  • Formaat: Spiral bound, 1344 pages, kõrgus x laius: 229x152 mm, kaal: 450 g
  • Ilmumisaeg: 18-Jun-2026
  • Kirjastus: Churchill Livingstone
  • ISBN-10: 0443433364
  • ISBN-13: 9780443433368
Teised raamatud teemal:
Find the essential information you need to safely administer more than 400 intravenous drugs! The newest edition of a reference trusted for more than 50 years, Elseviers 2027 Intravenous Medications is a concise, quick-access guide to complete, accurate drug information. New to this edition are 10-20 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.

Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more 50-year history of impeccable accuracy reinforces the importance of safe IV drug administration Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks Blue-screened text calls attention to other circumstances not covered by Black Box Warnings Dosage and dilution charts within monographs provide quick summaries of essential clinical information Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients Additional drug monographs are provided on the companion Evolve website





NEW! Drug monographs for approximately 10-20 newly approved drugs by the FDA include the most current information NEW! Updates with new interactions, precautions, alerts, drug uses, patient teaching instructions, and more are included throughout the guide to reflect changes and prevent medication dispensing errors NEW! QR codes for additional drug monographs enable quick access at the point of care
General Dilution Charts
How to Use This Book
Evolve Website Information
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
IV Drugs
Alphabetical Drug Monographs
Appendix A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
Appendix B: FDA Pregnancy Categories
Appendix C: U.S. Department of Health and Human Services, National Institutes
of Health, National Cancer Institute Common Terminology Criteria for Adverse
Events (CTCAE)
Appendix D: Information for Patients Receiving Immunosuppressive Agents
Appendix E: Recently Approved Drugs
Index
Shelly Collins, PharmD, has decades of clinical experience in which she has been responsible for overseeing system-wide pharmaceutical safety.